site stats

Phio pharmaceuticals fintel

WebbDeutsche Bank Ag\ closes position in PHIO / Phio Pharmaceuticals Corp Institutional Ownership: 13F and NPORT Filings The Security and Class in the table below are shown … Webb22 feb. 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology is designed to make immune cells more effective in killing tumor cells. Corporate Presentation The following is an investor update, effective January 2024, presented by Robert Bitterman. Mr.

PHIO / Phio Pharmaceuticals Corp - Forecast and Price Target

Webb30 mars 2024 · Phio Pharmaceuticals - PHIO News Today $5.99 +0.16 (+2.74%) (As of 03/30/2024 10:41 AM ET) Compare Today's Range $5.75 $5.99 50-Day Range $0.51 $6.85 52-Week Range $3.90 $29.04 Volume 1,039 shs Average Volume 36,447 shs Market Capitalization $6.89 million P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile … Webb22 feb. 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical-stage biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™)... fixfoot https://rubenamazion.net

BlackRock Inc. ownership in PHIO / Phio Pharmaceuticals Corp

Webb7 nov. 2024 · Phio Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its... PhioPharma @phio_pharma · May 3, 2024 WebbThe average one-year price target for Phio Pharmaceuticals is $73.44 The forecasts range from a low of $72.72 to a high of $75.60. Update Frequency: Monthly PHIO / Phio … Webb359 rader · Phio Pharmaceuticals Corp insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is … can mold harm cats

Investor Relations - Phio Pharmaceuticals

Category:Acciones Phio Pharma Cotización NASDAQ:PHIO hoy

Tags:Phio pharmaceuticals fintel

Phio pharmaceuticals fintel

Why did Phio Pharmaceuticals stock go up today? - MarketBeat

WebbFör 1 dag sedan · PHIO PHARMACEUTICALS CORP. : Financial news and information Stock PHIO PHARMACEUTICALS CORP. Nasdaq: PHIO Nasdaq PHIO PHARMACEUTICALS CORP. : Financial news and information Stock PHIO PHARMACEUTICALS CORP. Nasdaq: PHIO Nasdaq PHIO PHARMACEUTICALS CORP. … WebbPhio Pharmaceuticals Corp (PHIO) Stock Price Today, News, Quotes, FAQs and Fundamentals 8.50% KRYS 4.70% INFY 0.46% FAST 0.66% UNL 3.55% More …

Phio pharmaceuticals fintel

Did you know?

WebbPhio Pharmaceuticals stock is traded on Nasdaq as PHIO. The firm is headquartered in Marlborough, Ma. in Middlesex County. The firm's Chairman is Robert Bitterman, … WebbPhio Pharmaceuticals Our Science Our Science Overview Phio is addressing some of the biggest challenges in immuno-oncology (I/O) by developing therapeutics that leverage …

WebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology makes immune cells more effective in … WebbPhio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update. Additional Formats PDF Version. February 22, 2024 Phio Pharmaceuticals Appoints Robert Bitterman as President and Chief Executive Officer. Additional Formats PDF Version. February 13, 2024 ...

WebbPHIO - Phio Pharmaceuticals Corp. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save … WebbResumen PHIO Gráfico técnico Phio Pharmaceuticals Corp 5,527 + 0,259 ( + 4,92 %) S 1 semana 1 año Máx. Último cierre 5,268 Rango día 5,321 - 6 Ingresos - Apertura 5,321 52 semanas 3,9 - 29,04...

WebbPhio Pharmaceuticals Contact Us Contact Us Get in touch with us. General inquiries: [email protected] Investor relations information: [email protected] …

WebbPHIO / Phio Pharmaceuticals Corp Implied Volatility - Fintel Labs. Fintel ... fix folding closet door knobWebbPHIO Institutional Ownership, Sellers - Phio Pharmaceuticals Corp. Fintel ... can mold hurt catsWebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAI technology makes immune cells more effective in … fix footer to bottom bootstrapWebb6 apr. 2024 · Phio Pharmaceuticals (NASDAQ:PHIO) has a recorded net income of -$11.48 million. PHIO has generated -$10.68 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts … can mold harm your healthWebb13 apr. 2024 · Phio Pharmaceuticals Corporation Aktie ISIN: US71880W4024 · WKN: A3D451 · SYM: PHIO 5,710 USD -1,21 % -0,070 USD Letzter Kurs 06.04.23 · NYSE 5,440 USD 100 STK Geldkurs 06.04.23 6,000 USD 100... fix footer to bottom of screen cssWebb10 apr. 2024 · Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. About the company Risk Analysis Earnings have declined by 8.5% per year over past 5 years Has less than 1 year of cash runway Makes less than USD$1m in revenue ($0) Does not have a meaningful market cap ($7M) + 2 more risks See All Risk Checks … can mold illness cause hiatal herniaWebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAI technology makes immune cells more effective in killing tumor cells. INTASYL is the only self-delivering RNAi technology focused on immuno-oncology therapeutics. fix footer to bottom of screen bootstrap